Description
Sustanon 400 is a higher-concentration variant of the classical four-ester mixture with 400mg testosterone per ml. The split typically follows the Sustanon scheme with Propionate, Phenylpropionate, Isocaproate, and Decanoate in proportionally increased amounts.
Per study reports the higher concentration means less injection volume for the same dose. Instead of 1ml for 250mg, 0.625ml suffices for 250mg - a practical advantage in research protocols with high doses where volume tolerance and injection-site stress are factors.
The pharmacokinetics of the individual esters remain identical to standard Sustanon, only the total dose per ml is higher. This makes Sustanon 400 a tool for research protocols with supraphysiologic doses where volume at 1g/week or more would otherwise hit practical limits.
The higher concentration typically requires a slightly higher solvent concentration (benzyl benzoate, benzyl alcohol) in the vehicle. Post-injection inflammation can therefore be slightly elevated with Sustanon 400 compared to standard concentrations.
You can order Sustanon 400 as an oily injection solution in 10-vial packs at 400mg/ml.
This information is for research and educational purposes only. No medical recommendations.
Risks & Safety
Sustanon 400 shares the risk profile of all testosterone esters - the higher concentration per ml changes nothing about the documented effects, but the higher peak values usually require stronger E2 control.
Documented in studies and the application literature:
- Estrogen conversion: testosterone aromatizes to estradiol. With the higher peak values the E2 rise is usually more pronounced, with documented water retention, blood pressure rise and at higher doses gynecomastia risk.
- Suppression of endogenous production: exogenous testosterone throttles the body’s own production via the HPTA axis. Testicular atrophy and reduced fertility are documented, recovery after discontinuation is not guaranteed.
- Cardiovascular: studies describe unfavorable shifts in the lipid profile (HDL falls), elevated hematocrit and an associated thrombosis risk.
- Other: acne, accelerated hair loss with genetic predisposition. The elevated solvent concentration in the vehicle can slightly increase post-injection inflammation.
Baseline bloodwork before, during and after a research protocol is strongly advised. This classification does not replace medical advice. Risk and responsibility for any actual use lie entirely with the buyer.
Studies
- Comparative pharmacokinetics of testosterone esters - Testosterone (Springer) 1998, Behre & Nieschlag: Pharmacokinetics of the individual esters combined in the four-ester mixture.
- Pharmacokinetics of Testosterone Enanthate After Intramuscular Injection for Transgender Men - Androgens: Clinical Research and Therapeutics 2020, Ichihara et al: Recent pharmacokinetics of an intramuscular testosterone ester injection.
- The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal Men - New England Journal of Medicine 1996, Bhasin et al: Foundational study on supraphysiologic testosterone effects on muscle size and strength.
- Testosterone dose-response relationships in healthy young men - American Journal of Physiology-Endocrinology and Metabolism 2001, Bhasin et al: Dose-response study documenting dose-dependent effects on lean mass, hemoglobin and HDL across rising doses.
- Effects of Testosterone on Muscle Strength, Physical Function, Body Composition, and Quality of Life in Intermediate-Frail and Frail Elderly Men - The Journal of Clinical Endocrinology & Metabolism 2010, Srinivas-Shankar et al: Randomized placebo-controlled study on testosterone effects on strength and body composition.
